Literature DB >> 11882328

Endothelial markers and adhesion molecules in acute ischemic stroke--sequential change and differences in stroke subtype.

Kazuko Kozuka1, Tatsuo Kohriyama, Eiichi Nomura, Junko Ikeda, Hiroshi Kajikawa, Shigenobu Nakamura.   

Abstract

The progress of a stroke concerns the activation of endothelial cells and platelets. We measured the plasma activities of von Willebrand factor (vWf) and the serum levels of soluble thrombomodulin (sTM) as endothelial markers, and the plasma concentrations of soluble P-selectin (sP-selectin) and soluble E-selectin (sE-selectin) as adhesion molecules during the acute (within 48 h from onset) and subacute (after 1 month from the onset) phases of 52 consecutive patients with acute ischemic stroke and 86 age-matched control subjects. The plasma vWf activities and levels of sP-and sE-selectins in stroke patients were significantly elevated compared with those in controls during both the acute and subacute phases. The serum levels of sTM in stroke patients were significantly higher than those in controls only during the subacute phase. In atherothrombotic infarction, the vWf activities and the levels of sP-selectin, markers for endothelial and platelet activation, remained higher until the subacute phase compared with controls, and the concentrations of sTM, a marker for endothelial injury, were increased during the subacute phase compared with during the acute phase. In lacunar infarction, the levels of sTM and sE-selectin of patients were higher only during the acute phase than controls. These findings suggest that the endothelial cell damage might be maintained until the subacute phase in atherothrombotic infarction, whereas it is remarkable only during the acute phase in lacunar infarction. The evaluation of endothelial markers and adhesion molecules would represent the pathophysiological states of stroke and may provide useful information for the treatment of the ischemic infarction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882328     DOI: 10.1016/s0021-9150(01)00635-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  23 in total

1.  Chronic Systemic Immune Dysfunction in African-Americans with Small Vessel-Type Ischemic Stroke.

Authors:  Candice M Brown; Cheryl D Bushnell; Gregory P Samsa; Larry B Goldstein; Carol A Colton
Journal:  Transl Stroke Res       Date:  2015-09-15       Impact factor: 6.829

Review 2.  Endothelial Repair and Regeneration Following Intimal Injury.

Authors:  Belay Tesfamariam
Journal:  J Cardiovasc Transl Res       Date:  2016-01-21       Impact factor: 4.132

3.  Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.

Authors:  W O Tobin; J A Kinsella; G F Kavanagh; J S O'Donnell; R T McGrath; T Coughlan; D R Collins; D O'Neill; B Egan; S Tierney; T M Feeley; R P Murphy; D J H McCabe
Journal:  J Neurol       Date:  2014-04-30       Impact factor: 4.849

Review 4.  Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability.

Authors:  A Vilar-Bergua; I Riba-Llena; C Nafría; A Bustamante; V Llombart; P Delgado; J Montaner
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 5.  von Willebrand factor: an emerging target in stroke therapy.

Authors:  Simon F De Meyer; Guido Stoll; Denisa D Wagner; Christoph Kleinschnitz
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

6.  Thrombomodulin and High-Sensitive C-Reactive Protein Levels in Blood Correlate with the Development of Cerebral Infarction Among Asians.

Authors:  Yan Han; Shuai Wu; Qiang Hu; Jian-Qi Xiao; Dong-Mei Wei; Li-Li Liu; Ze-Zhi Li
Journal:  Mol Neurobiol       Date:  2015-07-02       Impact factor: 5.590

7.  Gene expression profiling of blood for the prediction of ischemic stroke.

Authors:  Boryana Stamova; Huichun Xu; Glen Jickling; Cheryl Bushnell; Yingfang Tian; Bradley P Ander; Xinhua Zhan; Dazhi Liu; Renee Turner; Peter Adamczyk; Jane C Khoury; Arthur Pancioli; Edward Jauch; Joseph P Broderick; Frank R Sharp
Journal:  Stroke       Date:  2010-08-26       Impact factor: 7.914

Review 8.  Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke.

Authors:  Xiaoye Mo; Ting Li; Guang Ji; Wei Lu; Zhiping Hu
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

9.  Systemic complement activation following human acute ischaemic stroke.

Authors:  E D Pedersen; U Waje-Andreassen; C A Vedeler; G Aamodt; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Association of E-selectin gene polymorphism (S128R) with ischemic stroke and stroke subtypes.

Authors:  Sitara Roy; Satrupa Das; Rakshith Danaboina; Vandana Sharma; Subhash Kaul; A Jyothy; Anjana Munshi
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.